Falipamil
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Citation bot (talk | contribs) at 18:25, 5 March 2020 (Alter: url, template type. Add: date, isbn, title, author pars. 1-1. Converted bare reference to cite template. | You can use this bot yourself. Report bugs here. | Activated by User:Grimes2 | Category:Lactams | via #UCB_Category). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:25, 5 March 2020 by Citation bot (talk | contribs) (Alter: url, template type. Add: date, isbn, title, author pars. 1-1. Converted bare reference to cite template. | You can use this bot yourself. Report bugs here. | Activated by User:Grimes2 | Category:Lactams | via #UCB_Category)
Names | |
---|---|
IUPAC name
2-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-5,6-dimethoxy-1-isoindolinone
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C24H32N2O5 | |
Molar mass | 428.52128 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Falipamil is a calcium channel blocker.[1]
References
- ^ Vaughan Williams, E. M. (2012-12-06). Antiarrhythmic Drugs. ISBN 9783642736667.
This biochemistry article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Falipamil&oldid=944097939"